Skip to main content
Quest Diagnostics

Data analysis: How the precision of real-world lab data transforms rare disease patient identification

Data Analysis

Diagnosing rare diseases like hypophosphatasia (HPP) is incredibly challenging, often resulting in years of misdiagnoses and delayed care when relying on claims data alone.

 

This comparative analysis demonstrates how integrating real-world lab data delivers the precise clinical signals needed to identify at-risk patients much earlier.

 

See how real-world lab data revealed clinical signals of HPP an average of 3.3 years sooner than a formal diagnosis appears in claims data.

Data analysis: How the precision of real-world lab data transforms rare disease patient identification

See the value of lab data in rare disease patient identification

921

* indicates required

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.